Investing.com - Merck&Co reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Merck&Co announced earnings per share of $1.4 on revenue of $12.08B. Analysts polled by Investing.com anticipated EPS of $1.61 on revenue of $12.63B.
Merck&Co shares are up 27% from the beginning of the year and are trading at $77.09 , down-from-52-week-high.They are outperforming the S&P 500 which is up 11.37% from the start of the year.
Merck&Co follows other major Healthcare sector earnings this month
Merck&Co's report follows an earnings beat by J&J on Tuesday, April 20, 2021, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Abbott Labs had beat expectations on Tuesday, April 20, 2021 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar